Awareness, Care & Treatment In Obesity Management - An International Observation Among Teens (ACTION Teens)
NCT05013359 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12987
Last updated 2022-02-02
Summary
ACTION Teens is a multinational cross-sectional survey-based study. The study consists of a quantitative online survey to be conducted among three groups of respondents in ten countries worldwide. The respondent population will include Adolescents Living with Obesity (ALwO), Caregivers of ALwO, and HCPs treating adolescents who have obesity.
The goal of this study is to provide insights to drive awareness around the needs of adolescents living with obesity and their caregivers, as well as to identify key areas of misalignment between adolescents, their caregivers and the HCPs involved in obesity treatment and management. ACTION Teens is designed to generate evidence to identify and address these challenges on both a global and local level, extending the insights from the previously conducted ACTION-IO study.
Conditions
Interventions
- OTHER
-
No treatment given
No treatment given
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Transparency (dept. 1452) · Novo Nordisk A/S
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-23
- Primary Completion
- 2021-12-13
- Completion
- 2021-12-13
Countries
- Australia
- Colombia
- Italy
- Mexico
- Saudi Arabia
- South Korea
- Spain
- Taiwan
- Turkey (Türkiye)
- United Kingdom
Study Locations
More Related Trials
-
STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
NCT06571383 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)
NCT00533598 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
NCT05035095 ·Status: COMPLETED ·Phase: PHASE3
-
Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.
NCT07154238 ·Status: ENROLLING_BY_INVITATION
-
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
NCT07253285 ·Status: RECRUITING ·Phase: PHASE3
-
Homeopathy for Overweight and Obesity in Mexican Adolescents
NCT03945396 ·Status: UNKNOWN ·Phase: PHASE2
-
Pilot Study With GFT505 (80mg) in Atherogenic Dyslipidaemic Patients With Abdominal Obesity
NCT01271751 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Patients Being Treated With Anti-obesity Medication
NCT06790160 ·Status: RECRUITING
-
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
NCT05051579 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
NCT02918279 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
NCT01789086 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
NCT04010786 ·Status: COMPLETED ·Phase: PHASE1
-
Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity
NCT05834062 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity
NCT06579092 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose Escalating Study to Assess the Safety and Tolerability of GT-001
NCT03490786 ·Status: COMPLETED ·Phase: PHASE1
-
A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany (WeGo Real Germany).
NCT07081178 ·Status: TERMINATED
-
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
NCT06672939 ·Status: RECRUITING ·Phase: PHASE3
-
"Efficacy in Adolescents of Continued Behavior Modification Following a Six Month Sibutramine-based Weight Management Intervention"
NCT01023139 ·Status: UNKNOWN ·Phase: NA
-
Cardiovascular System in Obesity: Effect of Treatment
NCT00000506 ·Status: COMPLETED ·Phase: PHASE2
-
B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)
NCT00302263 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
NCT05726227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Taldefgrobep Alfa in Adults With Overweight and Obesity
NCT07281495 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Young Adults With Early-onset Obesity Treated With Semaglutide
NCT05574439 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet
NCT05429593 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.
NCT00261911 ·Status: COMPLETED ·Phase: PHASE3